Friday, July 10, 2026

pharma · Mild/non-serious osteoarthritis (OA) of the knee.

Haleon - Gebro

HALEON AUSTRALIA PTY is a pharma organization headquartered in AU. Primary therapeutic focus areas include Mild/non-serious osteoarthritis (OA) of the knee.. NovaPharmaNews links 3 clinical program(s), 1 drug profile(s),

Fieberbrunn, AU HQ
179 Employees
TGA registrant Type
Company details
Status
Public
HQ
Fieberbrunn, AU
Employees
179
Programs
3
Drugs
9
Patents
0
Clinical program

300141

Phase 1 · other · Healthy volunteers, therapeutic indication not studied

300141 for Healthy volunteers, therapeutic indication not studied is a Phase 1 program (other) at HALEON AUSTRALIA PTY LTD with 1 ClinicalTrials.gov record(s).

Internal code 300141

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
HALEON AUSTRALIA PTY LTD
Phase
Phase 1
Modality
other
Indication
Healthy volunteers, therapeutic indication not studied
Status
active
Trials
1